The global gamma knife market is anticipated to reach a valuation of US$ 337.7 million in 2023, driven by ongoing research and development efforts. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 7.6% between 2023 and 2033, and reaching a total valuation of approximately US$ 702.5 million by 2033.
One of the major factors contributing to the growth of the gamma knife market is the global healthcare initiatives. Public and private initiatives aimed at improving healthcare infrastructure, especially in developing nations, can create opportunities for gamma knife providers to expand their reach.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-589
Offering comprehensive support services, including post treatment care and counseling, can enhance the overall patient experience and satisfaction. Efforts to harmonize regulatory standards across regions can simplify the approval process for gamma knife systems, making it easier to enter new markets.
The shift toward value based healthcare models, which focus on the quality and outcomes of care, can drive the adoption of technologies like gamma knife that offer high precision and effectiveness. Patients seeking high quality, cost effective treatment options may travel across borders to receive gamma knife treatment, creating opportunities for international patient referrals and collaborations between healthcare institutions.
There is a growing opportunity for the adoption of gamma knife systems, as healthcare infrastructure and access to advanced medical technologies improve in emerging markets. Advances in genomic profiling and molecular diagnostics can help identify patients who would benefit most from gamma knife radiosurgery, leading to targeted treatment plans.
The integration of remote monitoring and data analytics can enable healthcare providers to track patient outcomes, treatment effectiveness, and machine performance, leading to continuous improvement in gamma knife procedures.
The development of hybrid operating rooms, equipped with both surgical and radiological technologies, can promote the use of gamma knife alongside other surgical interventions. AI and machine learning applications can assist in treatment planning, making Gamma knife procedures even more precise and efficient.
Offering flexible financing options to patients can help make gamma knife treatment more accessible and affordable, driving patient demand. Focusing on improving the overall patient experience, including comfort and convenience during treatment, can be a differentiating factor for gamma knife centers.
Key Takeaways from the Market Study:
- Global gamma knife market was valued at US$ 313.8 million by 2022-end.
- From 2018 to 2022, the market demand expanded at a CAGR of 7.2%.
- The market in India is expected to expand at a CAGR of 11.4% through 2033.
- By disease, the brain metastases segment to account for a share of 69.2% in 2033.
- From 2023 to 2033, gamma knife market is expected to flourish at a CAGR of 7.6%.
- By 2033, the market value of gamma knife is expected to reach US$ 702.5 million.
Gamma knife can complement regenerative medicine and stem cell therapies by providing a precise means of targeting specific areas in the brain for treatment, remarks an FMI analyst.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-589
Competitive Landscape:
Prominent players in the gamma knife market are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, and Hitachi, Ltd., among others.
Recent Developments:
- In 2023, Varian announced the launch of its new Varian gamma knife icon system. The system features a more compact design, improved image guidance, and a faster treatment delivery system.
- In 2022, Akesis announced the launch of its new Akesis Galaxy SRS system. The system is the first and only gamma knife system to use a linear accelerator instead of a cobalt 60 source.
Segmentation Analysis of the Gamma Knife Market
By Disease Indication:
- Brain Metastasis
- Cancer
- Arteriovenous Malformation
- Trigeminal Neuralgia
- Others
By Anatomy:
- Head
- Neck
- Other Body Parts
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/589
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube